-
Sector Analysis
Chronic Hepatitis B (CHB) Epidemiology Analysis and Forecast to 2034
Chronic hepatitis B (CHB) is a liver disease caused by the hepatitis B virus (HBV). HBV is transmitted via blood, semen, and other body fluids, and is commonly spread through sexual contact, needle sharing, accidental needlesticks, and vertically from a pregnant person to the newborn (Mayo Clinic, 2024). HBV infection can be prevented with a vaccine. For most people, HBV infection is a short-term, acute illness resulting in a full recovery in less than six months. For others, infection lasts...
-
Sector Analysis
Paraguay and Panama Update Drug Pricing Methodology and Advance Towards International Reference Pricing
Paraguay and Panama are the latest countries in Latin America to have modernized and updated their drug pricing methodologies by finally adopting generalized International Reference Pricing (IRP) schemes.
-
Sector Analysis
Eosinophilic Esophagitis (EoE) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2030
This report covers the US and provides an Excel-based forecast model for the EoE market through 2030. The current standard of care for EoE includes proton pump inhibitors, swallowed topical corticosteroids, and dietary elimination approaches. While biologics such as dupilumab have introduced new options, many patients experience partial response, relapse upon treatment discontinuation, or challenges with long-term adherence to dietary regimens. The US EoE market is expected to grow to $1.2B, driven by the introduction of biologics and the late-stage...
-
Sector Analysis
Alzheimer’s Disease in 68 Markets - Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2033
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Alzheimer’s Disease market through 2033. GlobalData estimates that the value of the Alzheimer’s Disease (AD) market in the 8MM in 2023 was $2.4 billion. This market is defined as sales of symptamatic and disease modifying (DMT) treatments including including approval of anti-Aβmonoclonal antibodies (mAbs) across the 8MM. The US and China markets make up the majority of total global sales, contributing $1.1 billion (44.7%) and...
-
Sector Analysis
Alzheimer’s Disease in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033
The Alzheimer’s Disease therapeutics market is entering a period of significant expansion, supported by advances in disease-modifying treatments and the growing approval of anti-Aβ monoclonal antibodies. As treatment innovation accelerates and diagnosis improves, the market is poised for substantial long-term growth across major global healthcare systems. GlobalData estimates that the Alzheimer’s Disease (AD) market across the eight major markets (8MM)—the US, France, Germany, Italy, Spain, the UK, Japan, and China—was valued at $2.4 billion in 2023. The market encompasses sales...
-
Thematic Analysis
Pharmaceutical Drugs Development Annual Review by Key Companies, Sales, Trends and Competitive Analysis in 2024
This report investigates the year 2024 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize them within your sector.
-
Sector Analysis
Plaque Psoriasis in 68 Markets: Disease Overview, Product Profiles, Patient Flow, Competitive Assessment and Sales Forecast to 2030
This report covers the 68 geographical markets and provides an Excel-based forecast model for the Plaque Psoriasis (PsO) market through 2030. GlobalData estimated the value of the global PsO market to be $11.6 billion across the 7MM in 2020. By 2030, PsO sales across are expected to grow to $30.1 billion, representing a compound annual growth rate (CAGR) of 10.0% over the 10-year forecast period. Major drivers of growth in the PsO market over the forecast period include a steady...
-
Sector Analysis
Plaque Psoriasis Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2030
This report covers the 7 major markets and provides an Excel-based forecast model for the Plaque Psoriasis market through 2030. GlobalData estimated the value of the global PsO market to be $11.6 billion across the 7MM in 2020. By 2030, PsO sales across are expected to grow to $30.1 billion, representing a compound annual growth rate (CAGR) of 10.0% over the 10-year forecast period. Major drivers of growth in the PsO market over the forecast period include a steady increase...
-
Sector Analysis
Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Global Cannabis industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated operations. This encompasses licensing,...
-
Sector Analysis
Middle East and Africa (MEA) Cannabis Market Summary, Competitive Analysis and Forecast to 2029
Cannabis in Middle East & Africa industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Cannabis refers to a group of three psychoactive plants: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Our market scope includes both recreational and medicinal uses of cannabis, which are governed by regulated...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.